Metaphore Biotechnologies is harnessing the power of biomimicry and machine learning to unlock the transformative therapeutic potential of functional molecular mimics. The company’s MIMiC™ platform is a computationally driven bioplatform designing new therapeutics where function, specificity, and selectivity can be optimized. Metaphore is focused on making previously intractable drug targets accessible and unlocking breakthroughs that outperform today’s drugs for maximum patient impact.  

Metaphore was founded in 2021 in Flagship Labs, a unit of Flagship Pioneering.

Flagship Pioneering

Metaphore Biotechnologies

Congratulations to our Co-Founder and CEO Lovisa Afzelius for being recognized by PharmaVoice as a top 100 leader in the life science industry! Lovisa’s passion to drive the industry forward is apparent and we are proud to have her leading our team.

Read more about what keeps Lovisa inspired, what she sees as the future of AI, and more as she and her peers chart new paths: https://lnkd.in/evrPFA_x

We are proud to be one of four innovative bioplatform companies Flagship Pioneering has launched in the last year that are working to improve human health.  
 
At Metaphore, our mission is to harness the power of biomimicry to develop therapeutics that outperform today’s drugs and make previously intractable targets accessible. Read more: https://lnkd.in/eibnG2aM

We started with a question: “What if we could engineer therapeutics to trigger the desired biological response in a programmable way?”  
 
In nature, creatures have evolved to mimic each other for adaptive advantage. Take the owl butterfly, a physically vulnerable creature whose wings harness the power of an owl just by mimicking the image of the predator’s eye. We challenged ourselves to see how biomimicry could be applied to therapeutics, at a molecular level.  
 
Today, we introduce Metaphore Biotechnologies, founded by Flagship Pioneering as the answer to that challenge. We built Metaphore around the MIMiC™ platform, a premier computationally driven bioplatform designing new therapeutics where function, specificity, and selectivity can be optimized.  
 
We aspire to make therapeutics that outperform today’s drugs and reach patients with few or no therapeutic options. And we invite you to follow us as we go on that journey.  
 
Learn more: https://lnkd.in/eUYBxpzF
 
#FlagshipFounded #machinelearning

Metaphore Biotechnologies is a company harnessing the power of biomimicry and machine learning to unlock the transformative therapeutic potential of functional molecular mimics. Their MIMiC™ platform is a computationally driven bioplatform designing new therapeutics where function, specificity, and selectivity can be optimized. Metaphore is focused on making previously intractable drug targets accessible and unlocking breakthroughs that outperform today’s drugs for maximum patient impact.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Dec 1, 2023 12:17 AM	b3277970
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:METAPHOREBIO

Metaphore Biotechnologies